Dhanuka Realty Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Dhanuka Realty Ltd. from all sources in a single place.

10 Aug 2023, 09:02AM

25.25

-1.94%

At multi-year highs: DRL among 5 stocks witnessing 5-year swing high breakouts

Economic Times

A 5-year swing high represents the highest price a stock has reached within a five-year timeframe. This level acts as a significant resistance point where the price has historically struggled to go beyond

Dhanuka Realty Ltd. is trading above all available SMAs

Dhanuka Realty Ltd.

02 Aug 2023

25.25

-1.94%

At multi-year highs: DRL among 7 stocks that saw 5-year swing high breakout

Economic Times

Dhanuka Realty Ltd. has gained 68.33% in the last 6 Months

Dhanuka Realty Ltd.

19 Aug 2022

25.25

-1.94%

Mahindra to unveil Scorpio Classic's price tomorrow; check details here

Business Standard

According to a media report, the new and updated SUV comes with a restyled front bumper, Mahindra's 'twin-peaks' logo, and new LED DRLs

Dhanuka Realty Ltd. has gained 68.33% in the last 6 Months

Dhanuka Realty Ltd.

28 Jan 2022

25.25

-1.94%

DRL Q3 Results Preview: Profit may grow 25% YoY; margin likely to fall

Economic Times

Edelweiss sess profit rising 26.5 per cent YoY to Rs 780 crore. It sees sales rising 12.2 per cent YoY to Rs 5,531 crore. The brokerage sees Ebitda margin falling 14 basis points YoY to 22.7 per cent, with input cost headwinds partly compensated by plateauing SG&A investments.

Dhanuka Realty Ltd. has gained 68.33% in the last 6 Months

Dhanuka Realty Ltd.

21 Jan 2022

25.25

-1.94%

Viral vaccines, vector platforms may become new growth areas: DRL chief

Business Standard

In a Q&A, the chairman of Dr Reddy's Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November

Dhanuka Realty Ltd. is trading above all available SMAs

Dhanuka Realty Ltd.

01 Nov 2021

25.25

-1.94%

DRL's many pluses negated by regulatory hit

Economic Times

The operating margin of 27% has been above the company's long term guidance of 25%. However, the good performance was dented after the company disclosed being issued Form 483 containing eight observations from US drug regulator USFDA for two of its facilities at Duvvada in Andhra Pradesh. After surging over 5% following the results, the DRL stock finally closed at a gain of 2%.